secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRYO CELL INTERNATIONAL INC (CCEL)
CIK:        0000862692
Form:       8-K
Filed at:   2021-07-19T23:59:59+00:00
Accession:  0001564590-21-037044
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cryo-Cell Q2 fiscal 2021 revenue down 8% to $7.21M; net income rises to $1.17M
------------------------------------------------------------------------------

- Revenue $7.21M, down 8% from $7.87M; processing/storage fees $7.16M.
- Net income $1.17M ($0.15 basic EPS) vs $953K ($0.13) a year ago; net income up 23%.
- Cost of sales decreased 10% and SG&A decreased 12% year-over-year, offsetting revenue decline.
- Recorded $432K decrease in fair value of contingent consideration liability from Cord:Use earn-out; $240K amortization on Duke University license.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/862692/000156459021037044/0001564590-21-037044-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/862692/000156459021037044/ccel-8k_20210715.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-037044

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer